Treatment of multidrug-resistant Pseudomonas aeruginosa bacteremia using ceftolozane-tazobactam-based or colistin-based antibiotic regimens: A multicenter retrospective study

• Main Authors: Hakeam A. Hakeam (Author), Ghadi Askar (Author), Khalid Al Sulaiman (Author), Reem Mansour (Author), Maha M. Al Qahtani (Author), Dana Abbara (Author), Nada Aldhayyan (Author), Nariman Dyab (Author), Liyan Afaneh (Author), Muna Islami (Author), Zainab Al Duhailib (Author)
• Format: Book
• Published: Elsevier, 2022-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Ceftolozane-tazobactam is an emerging ‎treatment for severe infections caused by multidrug-resistant (MDR) Pseudomonas ‎aeruginosa. However, limited ‎data support its use in bacteremia treatment. This study aimed to assess the effectiveness of the treatment of MDR P. aeruginosa bacteremi...